See WP:MEDMOS for suggested additional sections
40% of patients with hereditary tyrosinemia develop hepatocellular carcinoma.
See WP:MEDMOS for suggested additional sections
40% of patients with hereditary tyrosinemia develop hepatocellular carcinoma.